ArticleFrontiers in bioengineering and biotechnology2026
Curdlan oligosaccharides induce salicylic acid-dependent defense responses in
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Long-term use of chemical pesticides has caused environmental and resistance-related concerns, highlighting the need for environmentally friendly plant immune inducers. This study aimed to prepare curdlan oligosaccharides (CDOS) and evaluate their immune-inducing activity in Arabidopsis thaliana. Methods: CDOS were prepared by enzymatic hydrolysis and purified by dialysis. Their structural characteristics were analyzed by TLC, FTIR, and ESI-MS. Antibacterial activity against Pseudomonas syringae pv. tomato DC3000 (Pst DC3000), disease resistance in A. thaliana, ROS accumulation, defense-related enzyme activities, and immune-related gene expression were further investigated. Results: The purified CDOS preparation mainly consisted of oligosaccharides with a degree of polymerization of 2-3, with a total sugar content of 81.62% and a residual protein content of 3.25%. CDOS showed no direct antibacterial activity against Pst DC3000 but significantly enhanced resistance in A. thaliana, reducing bacterial colonization by approximately 50% at 50 mg/L. CDOS also promoted ROS accumulation, increased POD, SOD, CAT, and PAL activities, and upregulated the SA-associated marker genes PR1, PR2, and PR5, whereas the JA-associated genes VSP and PDF1.2 were not significantly altered. The protective effect was impaired in SA-pathway-deficient mutants but retained in the JA-pathway mutant. Discussion: These findings indicate that CDOS functions primarily as a plant immune elicitor rather than a direct antibacterial agent, and its protective activity is closely associated with SA-dependent defense responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.